OXYGEN RADICALS, NEUTROPHILS AND MYOCARDIAL INJURY
OXYGEN RADICALS, NEUTROPHILS AND MYOCARDIAL INJURY
批准号:
3365906
负责人:
Rakesh C Kukreja
金额:
$18.16万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-01-01 至 1995-12-31
关键词:
calcium transporting ATPase electron microscopy electron spin resonance spectroscopy electrophysiology free radical oxygen heart contraction high performance liquid chromatography isolation perfusion laboratory rat myocardial ischemia /hypoxia neutrophil reperfusion sarcolemma sarcoplasmic reticulum singlet oxygen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ischemia/reperfusion (I/R) injury has been recognized to be an important
pathologic process; this is manifest clinically as reperfusion induced
arrhythmias, the phenomenon of myocardial stunning and an increase in the
rate of cell necrosis. Oxygen-derived free radicals have been implicated
as important mediators of this injury. The overall goals of the present
proposal are (a) to investigate if singlet oxygen is generated following
I/R, (b) to develop novel strategies to reduce this injury based on
singlet oxygen scavenging and (c) to study the underlying biochemical,
physiological and morphological mechanisms of injury. Accordingly, the
specific aims of the project are to test the following hypotheses. The
first hypothesis is that singlet oxygen is generated as a result of I/R
in the isolated perfused rat heart. Using electron paramagnetic
resonance (EPR), chemiluminescence and HPLC techniques we will measure
single oxygen generation. Specific singlet oxygen spin trap, 2,2,6,6-
tetramethylpiperidine (TEMP) will be used in EPR and HPLC measurements.
Specificity of singlet oxygen will be confirmed by scavengers such as
histidine, tryptophan and B-carotene. We will also monitor
contractility, arrhythmia, myocardial metabolism, cell membrane
hyperpermeability sarcolemmal and sarcoplasmic reticulum functions and
ultrastructural morphology. The second hypothesis is that singlet oxygen
inactivates Ca2+-ATPase enzyme of sarcoplasmic reticulum by aggregation
and fragmentation or by modification of amino acid residues. We shall
study the molecular structure of Ca2+-ATPase following exposure to
singlet oxygen. Using SDS-PAGE and HPLC techniques, we shall assess the
damage to the 97 K dalton monomer protein of Ca2+-ATPase and compare with
O2, H2O2 and OH radical. Protective effects of histidine, alpha-
tocopherol B-carotene and ascorbic acid will also be evaluated. The
third hypothesis is that singlet oxygen and activate neutrophils produce
significant mechanical and hemodynamic dysfunction, similar to I/R in the
isolated heart preparation. We will perfuse irradiated rose bengal and
activated neutrophils in the isolated perfused heart and monitor
isovolumetric left ventricular pressure, + and - dP/dt max, ECG and
coronary flow and measure sarcoplasmic reticulum function, sarcolemmal
Na+K+-ATPase activity, thiol groups and lipid peroxidation. The efficacy
of histidine beta-carotene, ascorbic acid, alpha-tocopherol (for singlet
oxygen), SOD, catalase, deferoxamine (O2, H2O2, OH radical human
platelets (which possess antioxidative activity) will be tested in this
model. the fourth hypothesis is that singlet oxygen itself is a direct,
negative inotropic species and exerts its negative inotropic action by
disrupting the excitation-contraction coupling system of cardiac muscle.
Using isolated papillary muscle isometric contraction model we shall
study the mechanical dysfunction associated with singlet oxygen injury
by monitoring alterations in contraction of the papillary muscle. The
effects of potential scavengers (protective, ameliorating effect and
recovery) will also be studied. This work will initiate one of the first
studies aimed at (1) measuring the generation of singlet oxygen following
I/R (2) demonstrating the physiological, biochemical and morphological
characterization of free radicals/neutrophils mediated injury. We
anticipate that our findings will foster a precise understanding of the
role and mechanism(s) of singlet oxygen mediated physiological and
biochemical events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:9788441
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:10242150
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
Amelioration of Doxorubicin Induced Muscle Dysfunction with Embryoinic stem cells-Derived Exosomes
-
批准号:10322656
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:10376557
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
-
批准号:8701394
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2013
-
负责人:Rakesh C Kukreja
-
依托单位:
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
-
批准号:8522552
-
项目类别:
-
资助金额:$47.87万
-
财政年份:2013
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7797605
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7617652
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:8258744
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:7867829
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:8056464
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7475537
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:8286343
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:8094423
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:7655523
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:6863287
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Effects of PDE-5 Inhibitors
-
批准号:8206609
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Effects of PDE-5 Inhibitors
-
批准号:7790958
-
项目类别:
-
资助金额:$44.85万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:7002638
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:7173444
-
项目类别:
-
资助金额:$45.05万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
海外基金